Atorvastatin effect on ulcerative colitis

Phase 2

• Conditions: lcerative colitis.; Ulcerative colitis, unspecified; K51.9

• Registration Number: IRCT20210713051878N1
• Lead Sponsor: Islamic Azad University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 21 November 2022

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

Patients in remission phase of ulcerative colitis
Age of between 18-65
Informed Consent

Exclusion Criteria

Pregnancy
Lactation
History of statin sensitivity

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Calprotectin detection by Radio immune assay. Timepoint: Measurement of Calprotectin at the beginning of the study and after 2 months. Method of measurement: Stool calprotectin measurement by Radio immune assay.